BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 24098947)

  • 41. Mitogen-activated protein kinase phosphatase-1 inhibition and sustained extracellular signal-regulated kinase 1/2 activation in camptothecin-induced human colon cancer cell death.
    Lee M; Young Kim S; Kim J; Kim HS; Kim SM; Kim EJ
    Cancer Biol Ther; 2013 Nov; 14(11):1007-15. PubMed ID: 24005240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis.
    Lee MJ; Lee JK; Choi JW; Lee CS; Sim JH; Cho CH; Lee KH; Cho IH; Chung MH; Kim HR; Ye SK
    PLoS One; 2012; 7(9):e38801. PubMed ID: 22962574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells.
    Park KW; Kundu J; Chae IG; Kim DH; Yu MH; Kundu JK; Chun KS
    Int J Oncol; 2014 Apr; 44(4):1309-15. PubMed ID: 24481553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bromoethylindole (BEI-9) redirects NF-κB signaling induced by camptothecin and TNFα to promote cell death in colon cancer cells.
    Chowdhury R; Gales D; Valenzuela P; Miller S; Yehualaeshet T; Manne U; Francia G; Samuel T
    Apoptosis; 2017 Dec; 22(12):1553-1563. PubMed ID: 29116428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenic death of colon cancer cells treated with oxaliplatin.
    Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
    Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
    Chakravarti N; Myers JN; Aggarwal BB
    Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells.
    Sreenivasan L; Li LV; Leclair P; Lim CJ
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.
    Huang C; Yang G; Jiang T; Huang K; Cao J; Qiu Z
    J Exp Clin Cancer Res; 2010 May; 29(1):51. PubMed ID: 20482858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway.
    Chen X; Yang W; Deng X; Ye S; Xiao W
    Mol Vis; 2020; 26():517-529. PubMed ID: 32818015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells.
    Wei X; Wang G; Li W; Hu X; Huang Q; Xu K; Lou W; Wu J; Liang C; Lou Q; Qian C; Liu L
    Oncol Rep; 2014 Jan; 31(1):335-41. PubMed ID: 24253664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
    Wang SW; Sun YM
    Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis.
    Odabaei G; Chatterjee D; Jazirehi AR; Goodglick L; Yeung K; Bonavida B
    Adv Cancer Res; 2004; 91():169-200. PubMed ID: 15327891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms.
    Yang Y; Yang L; Li Y
    Hum Pathol; 2018 Nov; 81():192-200. PubMed ID: 30420046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.
    Lin Q; Lai R; Chirieac LR; Li C; Thomazy VA; Grammatikakis I; Rassidakis GZ; Zhang W; Fujio Y; Kunisada K; Hamilton SR; Amin HM
    Am J Pathol; 2005 Oct; 167(4):969-80. PubMed ID: 16192633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease.
    Willson TA; Kuhn BR; Jurickova I; Gerad S; Moon D; Bonkowski E; Carey R; Collins MH; Xu H; Jegga AG; Guthery SL; Denson LA
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):32-43. PubMed ID: 22197944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
    Tian J; Chen X; Fu S; Zhang R; Pan L; Cao Y; Wu X; Xiao H; Lin HJ; Lo HW; Zhang Y; Lin J
    Breast Cancer Res Treat; 2019 Jun; 175(3):553-566. PubMed ID: 30852762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF
    Wang K; Li Y; Song N; Che X; Hou K; Xu L; Bai M; Wang Q; Wang Y; Zhou Y; Cao M; Liu Y; Zhang J
    J Cell Biochem; 2019 Apr; 120(4):5315-5325. PubMed ID: 30320916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-6--a key regulator of colorectal cancer development.
    Waldner MJ; Foersch S; Neurath MF
    Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.